Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuebijing Injection in Acute Exacerbations of COPD
ChiCTR-IPR-17011667Phase 4Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2017
- Countries
- 1
01
Overview
Phase 4, randomised trial of xuebijing in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Invasive mechanical ventilation rate. Started Jan 2017; status: recruiting.
02
Drugs
xuebijing
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-IPR-17011667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011667.